Related Experiment Video
Updated: Aug 18, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
Split-circulation assist device facilitates heart failure management and increases effects of intra-aortic balloon
F Miyawaki1, M Murata, F Mukai
1Department of Surgical Research, National Cardiovascular Center Research Institute, Osaka, Suita, Japan.
Insights
The novel split-circulation assist device (SCAD) enhances cardiac output monitoring and heart failure management. This device, combining an intra-aortic balloon pump and percutaneous cardiopulmonary support, aids in early detection of cardiac recovery.
Area of Science:
- Cardiovascular physiology
- Medical devices
- Critical care medicine
Background:
- Heart failure management requires effective circulatory support.
- Existing devices like intra-aortic balloon pumps (IABP) and percutaneous cardiopulmonary support (PCPS) have limitations.
- A need exists for advanced devices to improve cardiac output assessment and support.
Purpose of the Study:
- To introduce and evaluate the split-circulation assist device (SCAD) as a novel circulatory assist device.
- To assess the SCAD's ability to improve cardiac output monitoring and prediction.
- To determine the SCAD's potential to enhance cardiac assistance and facilitate patient management.
Main Methods:
- The SCAD combines IABP, PCPS, and dual aortic occlusion balloons.
- Animal experiments were conducted to compare SCAD with conventional IABP/PCPS combinations.
- Pressure and flow data were analyzed using multiple regression analysis.
Main Results:
- The SCAD demonstrated a significantly greater increase in aortic pressure response to cardiac output changes compared to controls.
- The SCAD facilitated more accurate prediction of cardiac outputs and loads by isolating aortic pressure from bypass flow.
- Enhanced cardiac assistance and increased IABP effectiveness were observed with the SCAD.
Conclusions:
- The SCAD is a potent new circulatory assist device.
- It enables earlier detection of cardiac recovery through improved cardiac output monitoring.
- The SCAD supports timely weaning from PCPS and improves heart failure management.
Abstract:
The split-circulation assist device (SCAD) comprises an intra-aortic balloon pump (IABP), percutaneous cardiopulmonary support (PCPS) equipment, and two occlusion balloons that occlude the descending thoracic aorta by alternate inflation. With the SCAD, the failing heart, assisted by IABP, maintains only the upper 25-30% of the entire circulation without any interference by bypass flow from PCPS. An animal experiment indicated that a given rise in cardiac output caused an increase in aortic pressure in the SCAD group about three times greater than that in the control group (an ordinary combination of IABP and PCPS). Thus, by causing greater increases in arterial pressure, the SCAD may make possible detection of subtle increases in cardiac output, and therefore early detection of cardiac recovery. Multiple regression analysis from the pressure and flow data obtained in another experiment indicated that the SCAD facilitated the prediction of cardiac outputs and loads by preventing the bypass flow rate from influencing the aortic pressure. In addition, the SCAD may enhance cardiac assistance by increasing the effects of IABP. Therefore, the SCAD is a useful and potent new circulatory assist device that can facilitate both timely weaning from PCPS and heart failure management.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Aortic Regurgitation IV: Nursing Management
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

